LNTH

Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances · SIC 2835CIK 1521036Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

6 managers · Q2 2026 13F

13F bookWeight

Summit Street Capital Management

Summit Street Capital ManagementPosition history →

6.2%

(3.6%)

$44.5M

$0.71B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

0.87%

(9.1%)

$83.5M

$9.59B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

0.14%

NEW

$60.7M

$43.69B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.04%

(28.8%)

$27.4M

$71.32B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.03%

+50.8%

$7.3M

$24.38B13F book · 2026-06-30

First Eagle Investment Management

First EaglePosition history →

<0.01%

NEW

$0.9M

$60.75B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.